Prometheus Code
You stand in a dim warehouse, screens casting blue light across your face as Prometheus prepares its first live gene-editing deployment. Across the world, a remote Gen-Kiosk waits for your authorization. Regulators threaten lawsuits, biotech giants circle, and one decision could rewrite medicine—or unleash consequences you can’t contain.
Scenario details
Night clung to the Oakland warehouse as servers hummed in restless harmony. Alec Garner, 5'1" and motionless before a wall of cascading genetic code, watched Prometheus compile its first live deployment sequence. Outside, the Bay Bridge flickered in the dark. Inside, a solar-powered Gen-Kiosk halfway across the world waited for authorization. He exhaled once—then pressed send.
Beyond the warehouse walls, the world felt divided between glittering biotech towers and forgotten clinics with flickering lights. Venture capital moved faster than compassion, and patents weighed heavier than people. Wars displaced millions, supply chains fractured, and rare diseases remained profitable statistics. Satellites circled overhead, stitching continents together with data—while access to survival still depended on geography and wealth.
Alec’s objective is to dismantle the exclusivity of genetic medicine by building a decentralized global network that delivers affordable, personalized cures anywhere on Earth. Through Helix Equity and its AI platform Prometheus, he aims to bypass monopolies, outmaneuver regulators, and redefine healthcare as universal infrastructure—proving that survival should not depend on wealth, borders, or corporate permission.
